MEDICAL UPDATE: Oral Ganciclovir Studies

MEDICAL UPDATE: Oral Ganciclovir Studies

Being Alive Newsletter; December 1992
Mark Katz MD and reported by Jim Stoecker

Studies are getting underway on the use of ganciclovir as prophylaxis for CMV. The study is open to anyone with less than 50 T-cells who has not had a bout of CMV disease. Two different dosages of ganciclovir will be looked at. One local study site is the Keith-Beer Medical Group; you can call them at 213.931.1463 for more information. CMV is the last major opportunistic infection with prophylaxis, and the possibility of oral ganciclovir filling this gap is very exciting.
921201
BA921206

AEGiS is made possible through unrestricted grants from Roxane Laboratories, the National Library of Medicine, and donations from users like you. Always watch for outdated information. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1992 - Beings Alive. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. Being Alive, 621 N. San Vicente Blvd., West Hollywood, CA 90069, Tel - 310.289.2551; FAX - 310.289.9866; Email: BeiAlive@aol.com http://www.beingalivela.org/

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1992. AEGIS.